Sona Nanotech Inc. operates as a nanotechnology life sciences company in the United States and Canada The company researchers and develops gold nanoparticles for potential therapies, including photothermal therapy, tumor targeting activity, anti-bacterial activity, and drug delivery vehicle, as well as diagnostics, such as diagnostic markers for imaging and immunoassay and biosensing. It also engages in the development of targeted hyperthermia therapy, a photo thermal therapy for the treatment of cancer tumors; and diagnostic tools comprising lateral flow assay rapid and bovine tuberculosis tests. The company was founded in 2013 and is based in Halifax, Canada.
Frequently asked questions
What sector does Sona Nanotech Inc (SONA) operate in?
Sona Nanotech Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Sona Nanotech Inc (SONA) current stock price?
As of the latest data, Sona Nanotech Inc stock price is CA$0.37, with a previous close of CA$0.36. Sona Nanotech Inc gained CA$0.01 in the last trading session, representing a 2.82% increase.
What is Sona Nanotech Inc (SONA) current market capitalization?
Sona Nanotech Inc market cap is approximately 41.75 million.
What is Sona Nanotech Inc (SONA) Earnings Per Share (EPS)?
The trailing EPS is -CA$0.02, and the forward EPS is -CA$0.06.
Does Sona Nanotech Inc (SONA) pay dividends?
No. Sona Nanotech Inc does not pay a dividend.
What is Sona Nanotech Inc (SONA) beta (volatility) score?
Sona Nanotech Inc has a beta of 0.985, meaning its volatility is roughly in line with the market.
